Test Price
2,800 AED✅ Home Collection Available
CTNNA2 Gene Neuronal Migration Disorder Genetic Test | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
This advanced genetic test detects pathogenic variants in the CTNNA2 gene associated with neuronal migration disorders using next-generation sequencing (NGS) on the Illumina NovaSeq X Plus platform, delivering 99.9% analytical sensitivity. The service includes temperature-controlled VIP mobile phlebotomy for home collection (daily 8 AM–11 PM), telephonic post-test clinical guidance by a board-certified clinical geneticist, and direct insurance billing verification via WhatsApp +971 54 548 8731. A comprehensive clinical report is issued within 21–28 calendar days under DHA- and ISO-accredited protocols.
Test Overview & Methodology
The CTNNA2 gene NGS test sequences the entire coding and splice-site regions to identify single-nucleotide variants, small insertions/deletions, and copy-number alterations implicated in neuronal migration disorders. Bioinformatic analysis is performed against GRCh38 with variant annotation from ClinVar and gnomAD, followed by orthogonal confirmation of clinically significant variants. The result enables precise diagnosis, prognostic stratification, and family risk assessment when correlated with the full clinical picture.
| Feature | Our Test (Premium) | Closest Alternative |
|---|---|---|
| Precision | NGS – Full Gene Sequencing (coding + splice sites) | Single-Gene Sanger or Panel |
| Methodology | Illumina NovaSeq X Plus Platform | Capillary Electrophoresis |
| Turnaround Time | 21–28 Calendar Days | 4–8 Weeks |
| Sample Types | Blood, FTA Card, Extracted DNA | Blood Only |
Physician Insight & Safety Protocols
“Understanding your genetic blueprint is a powerful step toward informed care. I encourage every patient to use this result as a foundation for dialogue with their neurologist and genetic counsellor rather than a standalone diagnosis. Variant interpretation must always be correlated with your complete clinical picture and family history for meaningful, safe guidance.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Reg: 9294403
Medication Advisory
⚠ Do not discontinue prescribed medication or alter treatment plans without consulting your doctor.
Safety Exclusion Criteria & ER Red Flags
- Exclusion: Inability to provide informed consent; recent allogeneic bone marrow transplant (may confound germline results).
- Exclusion: Sample collected outside sterile cold-chain protocol; gross hemolysis or insufficient DNA yield.
- ER Red Flag: If you experience acute neurological deterioration (seizure clusters, loss of consciousness, sudden vision loss), proceed to the nearest Emergency Department immediately—this test is not a substitute for urgent care.
Patient FAQ & Clinical Guidance
1. What does the CTNNA2 NGS test detect, and how reliable is it?
This test sequences the entire coding region of the CTNNA2 gene to identify single-nucleotide variants, small insertions/deletions, and copy-number changes linked to neuronal migration disorders—delivering 99.9% analytical sensitivity validated on the NovaSeq X Plus platform with orthogonal confirmation of clinically significant variants.
2. Why does the result take 3 to 4 weeks, and what happens during that time?
The 21-to-28-day turnaround encompasses DNA extraction, library preparation, high-depth NGS, bioinformatic alignment against GRCh38, variant calling using ClinVar and gnomAD population databases, and meticulous clinical interpretation by a board-certified molecular geneticist to ensure every report meets DHA‑MOHAP reporting standards.
3. Can children undergo this test, and what legal consents are needed in the UAE?
Yes, under Federal Decree‑Law No. 4 of 2016 on Medical Liability and Federal Law No. 2 of 2019 on the Use of ICT in Health Fields, a legal guardian must provide explicit written informed consent following a mandatory genetic counselling session. The child’s identity is protected under Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL), with results released solely to the authorized guardian and referring physician.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access‑controlled, and processed within accredited UAE facilities. We do not share identifiable information with third parties without explicit consent. For any data‑related inquiries, contact our Data Protection Officer at dpo@dnalabsuae.ae.
Clinical & Logistical Metadata
| Test Name | CTNNA2 Gene Neuronal Migration Disorder Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 21–28 Calendar Days |
| Sample Type / Matrix | Blood (Peripheral), FTA Card, Extracted DNA (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina NovaSeq X Plus |
| ICD-10-CM Code | Q04.8 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | DNA Labs UAE – DHA Facility License No.: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians